首页 > 最新文献

Przegla̜d Gastroenterologiczny最新文献

英文 中文
Biological rhythms of the gut and microbiota. 肠道和微生物群的生物节律。
IF 1.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-18 DOI: 10.5114/pg.2023.132437
Albert Chodowiec, Mirosław Tarasewicz, Anna Łokić, Marcin Kazberuk, Anatol Panasiuk

Numerous physiological processes occurring in the digestive system are subject to circadian rhythms, which are regulated by the endogenous biological clock. The motor activity of the small intestine, large intestine, and rectum operates in a 24-hour system, with significant differences between day and night periods. It is primarily correlated with the time of meals, hormone secretion rhythms, and other activities undertaken by the organism. In recent years, numerous scientific reports have emerged about the fundamental role of circadian rhythms in the proper functioning of the gut microbiota. In addition, the microbiota and its metabolites also influence the host's daily cycles, which affects the overall state of their organism. The aim of this review is to outline the mechanisms of action and interactions between biological rhythms, gut motility, and the functioning of the gut microbiota.

消化系统中的许多生理过程都受内源性生物钟调节的昼夜节律影响。小肠、大肠和直肠的运动活动以 24 小时制运行,昼夜之间存在显著差异。它主要与进餐时间、激素分泌节律以及机体进行的其他活动相关。近年来,许多科学报告都指出了昼夜节律在肠道微生物群正常运作中的基本作用。此外,微生物群及其代谢产物也影响着宿主的日周期,从而影响其机体的整体状态。本综述旨在概述生物节律、肠道运动和肠道微生物群功能之间的作用机制和相互作用。
{"title":"Biological rhythms of the gut and microbiota.","authors":"Albert Chodowiec, Mirosław Tarasewicz, Anna Łokić, Marcin Kazberuk, Anatol Panasiuk","doi":"10.5114/pg.2023.132437","DOIUrl":"https://doi.org/10.5114/pg.2023.132437","url":null,"abstract":"<p><p>Numerous physiological processes occurring in the digestive system are subject to circadian rhythms, which are regulated by the endogenous biological clock. The motor activity of the small intestine, large intestine, and rectum operates in a 24-hour system, with significant differences between day and night periods. It is primarily correlated with the time of meals, hormone secretion rhythms, and other activities undertaken by the organism. In recent years, numerous scientific reports have emerged about the fundamental role of circadian rhythms in the proper functioning of the gut microbiota. In addition, the microbiota and its metabolites also influence the host's daily cycles, which affects the overall state of their organism. The aim of this review is to outline the mechanisms of action and interactions between biological rhythms, gut motility, and the functioning of the gut microbiota.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"19 1","pages":"18-22"},"PeriodicalIF":1.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of left ventricular assist devices on 30-day readmission and outcomes in non-variceal upper gastrointestinal bleeding: a nationwide analysis. 左心室辅助装置对非静脉曲张性上消化道出血患者 30 天再入院率和预后的影响:一项全国性分析。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-18 DOI: 10.5114/pg.2023.134394
Umer Farooq, Zahid Ijaz Tarar, Adnan Malik, Muhammad Kashif Amin, Mustafa Gandhi, Moosa Tarar, Faisal Kamal

Introduction: Bleeding, especially non-variceal upper gastrointestinal bleeding (NVUGIB), remains the most common cause of readmission in left ventricular assist device (LVAD) patients. Any readmission after NVUGIB carries a worse prognosis.

Aim: To compare readmission outcomes in NVUGIB patients with and without LVAD.

Material and methods: We identified adult NVUGIB patients using the National Readmission Database 2018 employing International Classification of Diseases, Tenth Revision (ICD-10) codes. The patients were grouped based on LVAD history. Proportions were compared using the Fisher exact test, and multivariate Cox proportional regression analysis was used to compute adjusted p-values. We used Stata version 14.2 to perform analyses considering 2-sided p < 0.05 as statistically significant.

Results: The analysis included 322,342 NVUGIB patients, 1403 had a history of LVAD (mean age 64.25 years). The 30-day all-cause readmission rate in NVUGIB with LVAD was higher (24.31% vs. 13.92%, p < 0.001). Gastrointestinal bleeding as a readmission cause was more prevalent in the LVAD group. In patients with LVAD, NVUGIB readmissions required more complex endoscopic procedures, either requiring intervention during endoscopy or enteroscopy. There was no difference in mortality in NVUGIB readmissions (1.51% vs. 4.49%, p = 0.36); however, the length and cost of stay were higher in the LVAD group. Additionally, we identified novel independent predictors of readmission from NVUGIB in patients with LVADs.

Conclusions: Readmissions in NVUGIB patients after LVAD require complex haemostatic intervention and are associated with greater resource utilization. To reduce readmissions and associated healthcare costs, it is essential to identify high-risk patients.

导言:出血,尤其是非静脉曲张性上消化道出血(NVUGIB),仍然是左心室辅助装置(LVAD)患者再入院的最常见原因。目的:比较使用和未使用 LVAD 的 NVUGIB 患者的再入院结果:我们使用国际疾病分类第十次修订版(ICD-10)代码,通过2018年全国再入院数据库(National Readmission Database 2018)确定了成年NVUGIB患者。根据 LVAD 病史对患者进行分组。使用费舍尔精确检验比较比例,并使用多变量 Cox 比例回归分析计算调整后的 p 值。我们使用 Stata 14.2 版进行分析,将双侧 p < 0.05 视为具有统计学意义:分析对象包括 322,342 名 NVUGIB 患者,其中 1403 名患者有 LVAD 病史(平均年龄 64.25 岁)。使用 LVAD 的 NVUGIB 患者 30 天全因再入院率更高(24.31% 对 13.92%,P < 0.001)。胃肠道出血作为再入院原因在 LVAD 组中更为普遍。在使用 LVAD 的患者中,NVUGIB 再入院需要进行更复杂的内镜手术,要么需要在内镜检查期间进行干预,要么需要进行肠镜检查。NVUGIB 再入院患者的死亡率没有差异(1.51% vs. 4.49%,p = 0.36);但 LVAD 组患者的住院时间和费用更长。此外,我们还发现了LVAD患者NVUGIB再入院的新的独立预测因素:结论:LVAD术后NVUGIB患者的再入院治疗需要复杂的止血干预,并与更高的资源利用率相关。为了降低再入院率和相关医疗费用,必须识别高风险患者。
{"title":"Impact of left ventricular assist devices on 30-day readmission and outcomes in non-variceal upper gastrointestinal bleeding: a nationwide analysis.","authors":"Umer Farooq, Zahid Ijaz Tarar, Adnan Malik, Muhammad Kashif Amin, Mustafa Gandhi, Moosa Tarar, Faisal Kamal","doi":"10.5114/pg.2023.134394","DOIUrl":"https://doi.org/10.5114/pg.2023.134394","url":null,"abstract":"<p><strong>Introduction: </strong>Bleeding, especially non-variceal upper gastrointestinal bleeding (NVUGIB), remains the most common cause of readmission in left ventricular assist device (LVAD) patients. Any readmission after NVUGIB carries a worse prognosis.</p><p><strong>Aim: </strong>To compare readmission outcomes in NVUGIB patients with and without LVAD.</p><p><strong>Material and methods: </strong>We identified adult NVUGIB patients using the National Readmission Database 2018 employing International Classification of Diseases, Tenth Revision (ICD-10) codes. The patients were grouped based on LVAD history. Proportions were compared using the Fisher exact test, and multivariate Cox proportional regression analysis was used to compute adjusted <i>p</i>-values. We used Stata version 14.2 to perform analyses considering 2-sided <i>p</i> < 0.05 as statistically significant.</p><p><strong>Results: </strong>The analysis included 322,342 NVUGIB patients, 1403 had a history of LVAD (mean age 64.25 years). The 30-day all-cause readmission rate in NVUGIB with LVAD was higher (24.31% vs. 13.92%, <i>p</i> < 0.001). Gastrointestinal bleeding as a readmission cause was more prevalent in the LVAD group. In patients with LVAD, NVUGIB readmissions required more complex endoscopic procedures, either requiring intervention during endoscopy or enteroscopy. There was no difference in mortality in NVUGIB readmissions (1.51% vs. 4.49%, <i>p</i> = 0.36); however, the length and cost of stay were higher in the LVAD group. Additionally, we identified novel independent predictors of readmission from NVUGIB in patients with LVADs.</p><p><strong>Conclusions: </strong>Readmissions in NVUGIB patients after LVAD require complex haemostatic intervention and are associated with greater resource utilization. To reduce readmissions and associated healthcare costs, it is essential to identify high-risk patients.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"19 2","pages":"175-185"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11200072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141470337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study. 炎症性肠病 (IBD) 患者接种 SARS-CoV-2 疫苗--IBD 治疗是否会对 SARS-CoV-2 抗体产生负面影响?一项单中心前瞻性研究。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-07-27 DOI: 10.5114/pg.2023.130126
Katarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti, Katarzyna Maciejewska, Adam Tworek, Beata Stępień-Wrochna, Martyna Głuszek-Osuch, Michał Łodyga, Grażyna Rydzewska

Introduction: Inflammatory bowel disease (IBD) patients use a wide variety of immunosuppressive drugs, including biologics, but their effect on SARS-CoV-2 vaccine antibody levels remains a mystery.

Aim: We analysed whether the drugs used in the treatment of IBD patients could affect the concentration of SARS-CoV-2 antibodies.

Material and methods: This is a prospective, single-centre evaluation of the persistence of SARS-CoV-2 antibodies after vaccination at various time points: every 2 months throughout the 6th month after the first dose.

Results: We included a total of 346 vaccinated IBD patients in the study. A negative correlation between antibody level and time from full vaccination was confirmed for the following types of therapy: infliximab (rho = -0.32, p < 0.001), adalimumab (rho = -0.35, p = 0.025), and vedolizumab (rho = -0.50, p < 0.001). In the case of other, long-term drug administration, a negative correlation between antibody level and time from full vaccination was confirmed for mesalazine (rho = -0.35, p < 0.001), budesonide (rho = -0.58, p = 0.004), systemic glucocorticoids (rho = -0.58, p < 0.001), and azathioprine (rho = -0.44, p < 0.001).

Conclusions: Due to the immunosuppressive and biological treatment, IBD patients are exposed to a shorter persistence of SARS-CoV-2 antibodies and require booster doses. The role of gastroenterologists in educating patients about the need to continue SARS-CoV-2 vaccination remains crucial.

导言:目的:我们分析了治疗 IBD 患者的药物是否会影响 SARS-CoV-2 抗体的浓度:这是一项前瞻性的单中心评估,在不同的时间点评估接种疫苗后 SARS-CoV-2 抗体的持续性:从接种第一剂疫苗后的第 6 个月起,每 2 个月评估一次:研究共纳入了 346 名接种过疫苗的 IBD 患者。以下治疗类型的抗体水平与完全接种疫苗后的时间呈负相关:英夫利昔单抗(rho = -0.32,p < 0.001)、阿达木单抗(rho = -0.35,p = 0.025)和维多珠单抗(rho = -0.50,p < 0.001)。在其他长期用药的情况下,美沙拉嗪(rho = -0.35,p < 0.001)、布地奈德(rho = -0.58,p = 0.004)、全身糖皮质激素(rho = -0.58,p < 0.001)和硫唑嘌呤(rho = -0.44,p < 0.001)的抗体水平与完全接种时间呈负相关:由于免疫抑制和生物治疗,IBD 患者的 SARS-CoV-2 抗体持续时间较短,需要加强剂量。肠胃病专家在教育患者继续接种 SARS-CoV-2 疫苗方面的作用仍然至关重要。
{"title":"SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.","authors":"Katarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti, Katarzyna Maciejewska, Adam Tworek, Beata Stępień-Wrochna, Martyna Głuszek-Osuch, Michał Łodyga, Grażyna Rydzewska","doi":"10.5114/pg.2023.130126","DOIUrl":"10.5114/pg.2023.130126","url":null,"abstract":"<p><strong>Introduction: </strong>Inflammatory bowel disease (IBD) patients use a wide variety of immunosuppressive drugs, including biologics, but their effect on SARS-CoV-2 vaccine antibody levels remains a mystery.</p><p><strong>Aim: </strong>We analysed whether the drugs used in the treatment of IBD patients could affect the concentration of SARS-CoV-2 antibodies.</p><p><strong>Material and methods: </strong>This is a prospective, single-centre evaluation of the persistence of SARS-CoV-2 antibodies after vaccination at various time points: every 2 months throughout the 6<sup>th</sup> month after the first dose.</p><p><strong>Results: </strong>We included a total of 346 vaccinated IBD patients in the study. A negative correlation between antibody level and time from full vaccination was confirmed for the following types of therapy: infliximab (rho = -0.32, <i>p</i> < 0.001), adalimumab (rho = -0.35, <i>p</i> = 0.025), and vedolizumab (rho = -0.50, <i>p</i> < 0.001). In the case of other, long-term drug administration, a negative correlation between antibody level and time from full vaccination was confirmed for mesalazine (rho = -0.35, <i>p</i> < 0.001), budesonide (rho = -0.58, <i>p</i> = 0.004), systemic glucocorticoids (rho = -0.58, <i>p</i> < 0.001), and azathioprine (rho = -0.44, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Due to the immunosuppressive and biological treatment, IBD patients are exposed to a shorter persistence of SARS-CoV-2 antibodies and require booster doses. The role of gastroenterologists in educating patients about the need to continue SARS-CoV-2 vaccination remains crucial.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"1 1","pages":"198-205"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11200064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70475487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Helicobacter pylori infection and gastroesophageal reflux disease. 幽门螺杆菌感染与胃食管反流病的关系。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-12-02 DOI: 10.5114/pg.2024.145379
Seda Yılmaz, Kadir Gisi, Ali Cetinkaya, Bulent Kantarceken, Harun Ciralik

Introduction: Gastroesophageal reflux disease (GERD) is a common disease that negatively affects the quality of life, and its pathophysiology is multifactorial.

Aim: Our study aims to investigate the relationship between histological and topographic characteristics of Helicobacter pylori (H. pylori) gastritis and the symptoms, presence, and severity of oesophagitis in patients with reflux symptoms.

Material and methods: The symptoms, demographic data, and physical examination results of the patients admitted with gastrointestinal complaints were recorded and oesophagogastroduodenoscopies were performed. Biopsies were taken from the antrum and corpus.

Results: Of the 171 patients, 113 were in the reflux group and 58 were in the non-reflux group. 103 (60%) of the patients were female and 68 (40%) were male. The mean age was 40 ±14 years in the GERD group and 49 ±16 years in the non-reflux group. There were no statistically significant differences between both groups in terms of endoscopic results or the presence and degree of oesophagitis. The total H. pylori frequency was found to be 73%; 75% in the GERD group and 69% in the non-reflux group. There was no significant relationship between the presence and degree of reflux oesophagitis. Chronic inflammation and neutrophil activity were higher in the antrum and corpus in the H. pylori-positive group, and gland atrophy was detected more frequently in the antrum in the H. pylori-negative group.

Conclusions: The histological type of gastritis caused by H. pylori rather than the presence of H. pylori may be associated with GERD.

导言:目的:我们的研究旨在探讨幽门螺杆菌(H. pylori)胃炎的组织学和地形学特征与有反流症状的患者的症状、食道炎的存在和严重程度之间的关系:记录因胃肠道不适入院的患者的症状、人口统计学数据和体检结果,并进行食管胃十二指肠镜检查。结果:在 171 名患者中,113 人属于反流组,58 人属于非反流组。103名(60%)患者为女性,68名(40%)患者为男性。胃食管反流组的平均年龄为 40 ± 14 岁,非反流组的平均年龄为 49 ± 16 岁。两组患者在内窥镜检查结果、是否患有食道炎以及食道炎的程度方面没有明显的统计学差异。幽门螺杆菌的总感染率为 73%;胃食管反流患者为 75%,非反流组患者为 69%。反流性食管炎的存在与程度之间没有明显关系。幽门螺杆菌阳性组的胃窦和胃体中慢性炎症和中性粒细胞活性较高,幽门螺杆菌阴性组的胃窦腺体萎缩较常见:结论:幽门螺杆菌引起的胃炎的组织学类型而非幽门螺杆菌的存在可能与胃食管反流病有关。
{"title":"Relationship between <i>Helicobacter pylori</i> infection and gastroesophageal reflux disease.","authors":"Seda Yılmaz, Kadir Gisi, Ali Cetinkaya, Bulent Kantarceken, Harun Ciralik","doi":"10.5114/pg.2024.145379","DOIUrl":"10.5114/pg.2024.145379","url":null,"abstract":"<p><strong>Introduction: </strong>Gastroesophageal reflux disease (GERD) is a common disease that negatively affects the quality of life, and its pathophysiology is multifactorial.</p><p><strong>Aim: </strong>Our study aims to investigate the relationship between histological and topographic characteristics of <i>Helicobacter pylori</i> (<i>H. pylori</i>) gastritis and the symptoms, presence, and severity of oesophagitis in patients with reflux symptoms.</p><p><strong>Material and methods: </strong>The symptoms, demographic data, and physical examination results of the patients admitted with gastrointestinal complaints were recorded and oesophagogastroduodenoscopies were performed. Biopsies were taken from the antrum and corpus.</p><p><strong>Results: </strong>Of the 171 patients, 113 were in the reflux group and 58 were in the non-reflux group. 103 (60%) of the patients were female and 68 (40%) were male. The mean age was 40 ±14 years in the GERD group and 49 ±16 years in the non-reflux group. There were no statistically significant differences between both groups in terms of endoscopic results or the presence and degree of oesophagitis. The total <i>H. pylori</i> frequency was found to be 73%; 75% in the GERD group and 69% in the non-reflux group. There was no significant relationship between the presence and degree of reflux oesophagitis. Chronic inflammation and neutrophil activity were higher in the antrum and corpus in the <i>H. pylori</i>-positive group, and gland atrophy was detected more frequently in the antrum in the <i>H. pylori</i>-negative group.</p><p><strong>Conclusions: </strong>The histological type of gastritis caused by <i>H. pylori</i> rather than the presence of <i>H. pylori</i> may be associated with GERD.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"16 4","pages":"423-427"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review. 人工智能和图像处理在肝癌诊断、治疗和预后中的作用:综述。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-18 DOI: 10.5114/pg.2024.143147
Platon Dimopoulos, Admir Mulita, Andreas Antzoulas, Sylvain Bodard, Vasileios Leivaditis, Ioanna Akrida, Nikolaos Benetatos, Konstantinos Katsanos, Christos-Nikolaos Anagnostopoulos, Francesk Mulita

Artificial intelligence (AI) and image processing are revolutionising the diagnosis and management of liver cancer. Recent advancements showcase AI's ability to analyse medical imaging data, like computed tomography scans and magnetic resonance imaging, accurately detecting and classifying liver cancer lesions for early intervention. Predictive models aid prognosis estimation and recurrence pattern identification, facilitating personalised treatment planning. Image processing techniques enhance data analysis by precise segmentation of liver structures, fusion of information from multiple modalities, and feature extraction for informed decision-making. Despite progress, challenges persist, including the need for standardised datasets and regulatory considerations.

人工智能(AI)和图像处理正在彻底改变肝癌的诊断和管理。最近的进展表明,人工智能能够分析医学成像数据,如计算机断层扫描和磁共振成像,准确检测和分类肝癌病变,以便进行早期干预。预测模型有助于预后估计和复发模式识别,促进个性化治疗计划。图像处理技术通过精确分割肝脏结构、融合来自多种模式的信息以及提取特征以做出明智的决策来增强数据分析。尽管取得了进展,但挑战依然存在,包括对标准化数据集的需求和监管方面的考虑。
{"title":"The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review.","authors":"Platon Dimopoulos, Admir Mulita, Andreas Antzoulas, Sylvain Bodard, Vasileios Leivaditis, Ioanna Akrida, Nikolaos Benetatos, Konstantinos Katsanos, Christos-Nikolaos Anagnostopoulos, Francesk Mulita","doi":"10.5114/pg.2024.143147","DOIUrl":"10.5114/pg.2024.143147","url":null,"abstract":"<p><p>Artificial intelligence (AI) and image processing are revolutionising the diagnosis and management of liver cancer. Recent advancements showcase AI's ability to analyse medical imaging data, like computed tomography scans and magnetic resonance imaging, accurately detecting and classifying liver cancer lesions for early intervention. Predictive models aid prognosis estimation and recurrence pattern identification, facilitating personalised treatment planning. Image processing techniques enhance data analysis by precise segmentation of liver structures, fusion of information from multiple modalities, and feature extraction for informed decision-making. Despite progress, challenges persist, including the need for standardised datasets and regulatory considerations.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"19 3","pages":"221-230"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic management of bleeding ectopic varices: multicentric retrospective case series. 内镜下治疗出血异位静脉曲张:多中心回顾性病例系列
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-08-02 DOI: 10.5114/pg.2023.130201
Mohamed Ali El-Nady, Mahmoud Wahba, Oussama Ebada, Mamdouh Gabr, Kareem Essam, Abeer Abdellatef, Mohammed Ewid, Hyam Fathy, Mazen Naga, Ahmed Altonbary

Introduction: Portal hypertension is a common complication of liver cirrhosis. Varices are dilated collaterals that develop as a result of portal hypertension at the level of the porto-systemic connections and can cause a shift in the blood flow from high to low pressure. Common locations for porto-systemic shunts are the lower oesophagus and the gastric fundus. Ectopic varices are defined as dilated tortuous veins located at unusual sites other than the gastro-oesophageal junction.

Aim: This research aimed to study the endoscopic assessment of ectopic varices as well as necessary haemostatic interventions to our best knowledge. Also, to perform a review of the literature to compare our results to the most recent available data.

Material and methods: Our group extracted endoscopic reports of patients presenting to the emergency department with evidence of recent GI bleeding in whom ectopic varices were identified. We reported all interventions or procedures needed, details of hospitalization, radiological and laboratory results, as well as follow-up charts.

Results: Our study included 95 patients presenting to the emergency department with evidence of active GI bleeding. Ectopic varices were identified as the source of bleeding in 28 cases. Bleeding from duodenal varices was found in 17 patients and rectal varices in 9 patients. Endoscopic management was used for all cases with active bleeding. Rebleeding from ectopic varices was found in 5 cases, for whom interventional radiology was performed. All cases with rebleeding were duodenal varices. Early mortality occurred in 3 cases after re-intervention.

Conclusions: Our study describes a series of patients with ectopic varices discovered upon emergency endoscopy. Rectal varices were the most commonly found in our series. Bleeding and the need for re-intervention is more common in duodenal varices.

{"title":"Endoscopic management of bleeding ectopic varices: multicentric retrospective case series.","authors":"Mohamed Ali El-Nady, Mahmoud Wahba, Oussama Ebada, Mamdouh Gabr, Kareem Essam, Abeer Abdellatef, Mohammed Ewid, Hyam Fathy, Mazen Naga, Ahmed Altonbary","doi":"10.5114/pg.2023.130201","DOIUrl":"10.5114/pg.2023.130201","url":null,"abstract":"<p><strong>Introduction: </strong>Portal hypertension is a common complication of liver cirrhosis. Varices are dilated collaterals that develop as a result of portal hypertension at the level of the porto-systemic connections and can cause a shift in the blood flow from high to low pressure. Common locations for porto-systemic shunts are the lower oesophagus and the gastric fundus. Ectopic varices are defined as dilated tortuous veins located at unusual sites other than the gastro-oesophageal junction.</p><p><strong>Aim: </strong>This research aimed to study the endoscopic assessment of ectopic varices as well as necessary haemostatic interventions to our best knowledge. Also, to perform a review of the literature to compare our results to the most recent available data.</p><p><strong>Material and methods: </strong>Our group extracted endoscopic reports of patients presenting to the emergency department with evidence of recent GI bleeding in whom ectopic varices were identified. We reported all interventions or procedures needed, details of hospitalization, radiological and laboratory results, as well as follow-up charts.</p><p><strong>Results: </strong>Our study included 95 patients presenting to the emergency department with evidence of active GI bleeding. Ectopic varices were identified as the source of bleeding in 28 cases. Bleeding from duodenal varices was found in 17 patients and rectal varices in 9 patients. Endoscopic management was used for all cases with active bleeding. Rebleeding from ectopic varices was found in 5 cases, for whom interventional radiology was performed. All cases with rebleeding were duodenal varices. Early mortality occurred in 3 cases after re-intervention.</p><p><strong>Conclusions: </strong>Our study describes a series of patients with ectopic varices discovered upon emergency endoscopy. Rectal varices were the most commonly found in our series. Bleeding and the need for re-intervention is more common in duodenal varices.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"1 1","pages":"271-276"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70475200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020. 乌克兰胃癌:2003年至2020年的流行病学数据及其分类学结构。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-02-02 DOI: 10.5114/pg.2024.134840
Yevgen O Chernov, Valeriia Haysanovska, Olha V Makarenko

Introduction: Gastric cancer is one of the world's leading causes of death due to oncological diseases. Gastric cancer comprises a diverse group of diseases that includes several oncological units.

Aim: To analyse the nosological structure of epidemiological data related to gastric cancer in Ukraine and compare it with global trends from 2003 to 2020.

Material and methods: The data were retrieved from the National Cancer Registry of Ukraine and analysed using MedCalc for Windows, version 20.218 (MedCalc Software, Ostend, Belgium).

Results: Eight forms of gastric cancer were diagnosed every year. The lowest incidence rate was in 2020, with 8.99 per 100,000 people/year. This was a 33.71% drop compared to 2005 (p < 0.0001). Adenocarcinoma constituted the largest part of the cases over the 2003 to 2020 period: 96.38% (95% CI: 95.02-97.05%). All the other types of gastric cancer together comprised 2.97% (95% CI: 2.34-3.76%) of the cases. The number of adenocarcinoma cases as well as its incidence rate decreased in 2003-2020 in Ukraine. The incidence rate of all types of gastric cancer was seen to decrease over the 2003-2020 timeframe in Ukraine. Adenocarcinoma was the leading form of gastric cancer in the country, and other types were uncommon in both Ukraine and the rest of the world. There was a change in the incidence rates of the other forms of gastric cancer, but those incidences did not notably affect the structure of the epidemiological data.

Conclusions: The total number of cases of gastric cancer, as well as its incidence rate, decreased in Ukraine from 2003 to 2020. This situation corresponds with global tendencies.

简介胃癌是世界上因肿瘤疾病导致死亡的主要原因之一。目的:分析乌克兰胃癌相关流行病学数据的命名结构,并将其与 2003 年至 2020 年的全球趋势进行比较:数据取自乌克兰国家癌症登记处,使用MedCalc for Windows 20.218版(比利时奥斯坦德MedCalc软件公司)进行分析:结果:每年诊断出八种胃癌。2020 年的发病率最低,为每 10 万人每年 8.99 例。与 2005 年相比,下降了 33.71%(p < 0.0001)。腺癌是 2003 年至 2020 年期间发病率最高的癌症:96.38%(95% CI:95.02-97.05%)。所有其他类型的胃癌加在一起占病例总数的 2.97%(95% CI:2.34-3.76%)。2003-2020 年间,乌克兰的腺癌病例数及其发病率均有所下降。2003-2020年期间,乌克兰所有类型胃癌的发病率均有所下降。腺癌是乌克兰胃癌的主要类型,其他类型的胃癌在乌克兰和世界其他地区都不常见。其他类型胃癌的发病率有所变化,但这些发病率并未对流行病学数据的结构产生显著影响:结论:2003 年至 2020 年期间,乌克兰的胃癌病例总数及其发病率均有所下降。这种情况符合全球趋势。
{"title":"Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020.","authors":"Yevgen O Chernov, Valeriia Haysanovska, Olha V Makarenko","doi":"10.5114/pg.2024.134840","DOIUrl":"10.5114/pg.2024.134840","url":null,"abstract":"<p><strong>Introduction: </strong>Gastric cancer is one of the world's leading causes of death due to oncological diseases. Gastric cancer comprises a diverse group of diseases that includes several oncological units.</p><p><strong>Aim: </strong>To analyse the nosological structure of epidemiological data related to gastric cancer in Ukraine and compare it with global trends from 2003 to 2020.</p><p><strong>Material and methods: </strong>The data were retrieved from the National Cancer Registry of Ukraine and analysed using MedCalc for Windows, version 20.218 (MedCalc Software, Ostend, Belgium).</p><p><strong>Results: </strong>Eight forms of gastric cancer were diagnosed every year. The lowest incidence rate was in 2020, with 8.99 per 100,000 people/year. This was a 33.71% drop compared to 2005 (p < 0.0001). Adenocarcinoma constituted the largest part of the cases over the 2003 to 2020 period: 96.38% (95% CI: 95.02-97.05%). All the other types of gastric cancer together comprised 2.97% (95% CI: 2.34-3.76%) of the cases. The number of adenocarcinoma cases as well as its incidence rate decreased in 2003-2020 in Ukraine. The incidence rate of all types of gastric cancer was seen to decrease over the 2003-2020 timeframe in Ukraine. Adenocarcinoma was the leading form of gastric cancer in the country, and other types were uncommon in both Ukraine and the rest of the world. There was a change in the incidence rates of the other forms of gastric cancer, but those incidences did not notably affect the structure of the epidemiological data.</p><p><strong>Conclusions: </strong>The total number of cases of gastric cancer, as well as its incidence rate, decreased in Ukraine from 2003 to 2020. This situation corresponds with global tendencies.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"16 4","pages":"428-433"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing surgical prehabilitation through microbiota modulation. 通过微生物群调节推进手术康复。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-12-11 DOI: 10.5114/pg.2024.145831
Wojciech Marlicz, Grażyna Rydzewska
{"title":"Advancing surgical prehabilitation through microbiota modulation.","authors":"Wojciech Marlicz, Grażyna Rydzewska","doi":"10.5114/pg.2024.145831","DOIUrl":"10.5114/pg.2024.145831","url":null,"abstract":"","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"16 4","pages":"345-346"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease. 炎症性肠病患者感染艰难梭菌的风险因素分析。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-18 DOI: 10.5114/pg.2024.143145
Alicja Jakubowska, Dorota Szydlarska, Grażyna Rydzewska

Introduction: Clostridioides difficile infection (CDI) is one of the most important challenges in contemporary gastroenterology. However, data from CDI studies are sometimes contradictory.

Aim: To analyse the risk factors for CDI in patients with inflammatory bowel disease (IBD).

Material and methods: This is a retrospective analysis of the medical records of 204 patients (77 IBD with CDI, 50 with IBD without CDI, and a control group of 77) hospitalised in a referral centre in Warsaw. Data were entered and analysed by using univariate logistic regression models.

Results: Patients with IBD and CDI had significantly longer hospitalisation time than patients with IBD without CDI. The population of patients with CDI and IBD was statistically significantly younger (p < 0.001). Patients with IBD and CDI had a lower body mass index (p < 0.001) and were more often treated with antibiotics (p < 0.001). Prior antibiotic use (< 1 month) was a risk factor for CDI (p = 0.003). Lower body mass index (p < 0.001) and lower levels of albumins (p = 0.036) were strong risk factors for CDI in the study group. Additional risk factors were young age (p < 0.001), length of hospitalisation (p = 0.001), treatment with glucocorticosteroids (p = 0.001), immunosuppressive treatment (p = 0.001), and gastritis and/or duodenitis (p = 0.002). The study did not confirm that proton pump inhibitors or biologic treatment affected the risk of CDI.

Conclusions: The risk factors for CDI in patients with IBD include younger age, female gender, low body mass index and hypoalbuminaemia, use of thiopurines, antibiotics, and glucocorticosteroids, prolonged hospitalisation, and gastritis and/or duodenitis.

艰难梭菌感染(CDI)是当代胃肠病学最重要的挑战之一。然而,来自CDI研究的数据有时是相互矛盾的。目的:分析炎症性肠病(IBD)患者发生CDI的危险因素。材料和方法:回顾性分析了在华沙转诊中心住院的204例患者(77例IBD合并CDI, 50例IBD不合并CDI, 77例对照组)的医疗记录。输入数据并使用单变量逻辑回归模型进行分析。结果:IBD合并CDI患者的住院时间明显长于不合并CDI的IBD患者。CDI和IBD患者的年轻化有统计学意义(p < 0.001)。IBD和CDI患者的体重指数较低(p < 0.001),并且更常使用抗生素治疗(p < 0.001)。既往使用抗生素(< 1个月)是CDI的危险因素(p = 0.003)。在研究组中,较低的身体质量指数(p < 0.001)和较低的白蛋白水平(p = 0.036)是CDI的强烈危险因素。其他危险因素包括年轻(p < 0.001)、住院时间(p = 0.001)、糖皮质激素治疗(p = 0.001)、免疫抑制治疗(p = 0.001)、胃炎和/或十二指肠炎(p = 0.002)。该研究没有证实质子泵抑制剂或生物治疗影响CDI的风险。结论:IBD患者CDI的危险因素包括年龄较小、女性、低体重指数和低白蛋白血症、使用硫嘌呤、抗生素和糖皮质激素、长期住院以及胃炎和/或十二指肠炎。
{"title":"Analysis of risk factors of <i>Clostridioides difficile</i> infection in patients with inflammatory bowel disease.","authors":"Alicja Jakubowska, Dorota Szydlarska, Grażyna Rydzewska","doi":"10.5114/pg.2024.143145","DOIUrl":"10.5114/pg.2024.143145","url":null,"abstract":"<p><strong>Introduction: </strong><i>Clostridioides difficile</i> infection (CDI) is one of the most important challenges in contemporary gastroenterology. However, data from CDI studies are sometimes contradictory.</p><p><strong>Aim: </strong>To analyse the risk factors for CDI in patients with inflammatory bowel disease (IBD).</p><p><strong>Material and methods: </strong>This is a retrospective analysis of the medical records of 204 patients (77 IBD with CDI, 50 with IBD without CDI, and a control group of 77) hospitalised in a referral centre in Warsaw. Data were entered and analysed by using univariate logistic regression models.</p><p><strong>Results: </strong>Patients with IBD and CDI had significantly longer hospitalisation time than patients with IBD without CDI. The population of patients with CDI and IBD was statistically significantly younger (<i>p</i> < 0.001). Patients with IBD and CDI had a lower body mass index (<i>p</i> < 0.001) and were more often treated with antibiotics (<i>p</i> < 0.001). Prior antibiotic use (< 1 month) was a risk factor for CDI (<i>p</i> = 0.003). Lower body mass index (<i>p</i> < 0.001) and lower levels of albumins (<i>p</i> = 0.036) were strong risk factors for CDI in the study group. Additional risk factors were young age (<i>p</i> < 0.001), length of hospitalisation (<i>p</i> = 0.001), treatment with glucocorticosteroids (<i>p</i> = 0.001), immunosuppressive treatment (<i>p</i> = 0.001), and gastritis and/or duodenitis (<i>p</i> = 0.002). The study did not confirm that proton pump inhibitors or biologic treatment affected the risk of CDI.</p><p><strong>Conclusions: </strong>The risk factors for CDI in patients with IBD include younger age, female gender, low body mass index and hypoalbuminaemia, use of thiopurines, antibiotics, and glucocorticosteroids, prolonged hospitalisation, and gastritis and/or duodenitis.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"19 3","pages":"277-283"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial profile of biliary tract infection in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography (ERCP), and baseline risk factors predicting microbial growth and post-ERCP cholangitis. 接受治疗性内镜逆行胰胆管造影术(ERCP)患者胆道感染的微生物概况,以及预测微生物生长和ERCP术后胆管炎的基线风险因素。
IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-11 DOI: 10.5114/pg.2024.136226
Hina Ismail, Raja Taha Yaseen Khan, Syed Mudassir Laeeq, Zain Majid, Abbas Ali Tasneem, Farina M Hanif, Nasir Hasan Luck

Introduction: Stasis of bile flow can result in microbial colonization of the biliary tree. Cholangitis is a common adverse event linked to endoscopic retrograde cholangiopancreatography (ERCP).

Aim: To establish the bacterial profiles isolated from the bile sample and to evaluate the pre-ERCP risk factors predicting the microbial growth and development of post-ERCP cholangitis (PEC).

Material and methods: This was a prospective cohort study, which was conducted at the Department of Hepato-gastroenterology, SIUT from 1 January 2021 to 31 December 2021. Patients of either gender undergoing index ERCP procedure were included in the study. All the patients underwent ERCP, and bile culture (BC) aspirated immediately after cannulation was achieved prior to the contrast injection. There were 2 outcome variables. One was the presence or absence of organisms in bile culture, and the second one was the development of PEC.

Results: The total number of patients was 280. Bile culture was positive in 195 (69.6%) patients, and post-ERCP cholangitis developed in 187 (66.8%) patients. The most common organism in BC was Escherichia coli (E. coli), in 82 (42%) patients. History of jaundice, abdominal pain, and weight loss on admission along with ERCP performed for common bile duct (CBD) stricture were independent predictors of positive BC and PEC, while advanced age was an additional risk factor for PEC.

Conclusions: Microbial profile and risk factors for positive BC and PEC were evaluated. Advanced age, pre-operative jaundice, and prolonged biliary stasis are the independent risk factors for these conditions.

胆汁流动停滞可导致微生物在胆道树的定植。胆管炎是内镜逆行胆管造影术(ERCP)的常见不良事件。目的:建立胆汁中分离的细菌谱,评价预测ercp后胆管炎(PEC)微生物生长和发展的危险因素。材料和方法:这是一项前瞻性队列研究,于2021年1月1日至2021年12月31日在SIUT肝消化内科进行。接受指数ERCP手术的患者不分性别均被纳入研究。所有患者均行ERCP,注射造影剂前插管后立即行胆汁培养(BC)。有两个结果变量。一个是胆汁培养中是否存在微生物,第二个是PEC的发展。结果:患者总数280例。195例(69.6%)患者胆汁培养阳性,187例(66.8%)患者发生ercp后胆管炎。BC中最常见的细菌是大肠杆菌(E. coli),有82例(42%)患者。入院时黄疸史、腹痛和体重减轻以及因胆总管(CBD)狭窄进行ERCP是BC和PEC阳性的独立预测因素,而高龄是PEC的另一个危险因素。结论:对BC和PEC阳性患者的微生物特征和危险因素进行了评估。高龄、术前黄疸和长期胆汁淤积是这些疾病的独立危险因素。
{"title":"Microbial profile of biliary tract infection in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography (ERCP), and baseline risk factors predicting microbial growth and post-ERCP cholangitis.","authors":"Hina Ismail, Raja Taha Yaseen Khan, Syed Mudassir Laeeq, Zain Majid, Abbas Ali Tasneem, Farina M Hanif, Nasir Hasan Luck","doi":"10.5114/pg.2024.136226","DOIUrl":"10.5114/pg.2024.136226","url":null,"abstract":"<p><strong>Introduction: </strong>Stasis of bile flow can result in microbial colonization of the biliary tree. Cholangitis is a common adverse event linked to endoscopic retrograde cholangiopancreatography (ERCP).</p><p><strong>Aim: </strong>To establish the bacterial profiles isolated from the bile sample and to evaluate the pre-ERCP risk factors predicting the microbial growth and development of post-ERCP cholangitis (PEC).</p><p><strong>Material and methods: </strong>This was a prospective cohort study, which was conducted at the Department of Hepato-gastroenterology, SIUT from 1 January 2021 to 31 December 2021. Patients of either gender undergoing index ERCP procedure were included in the study. All the patients underwent ERCP, and bile culture (BC) aspirated immediately after cannulation was achieved prior to the contrast injection. There were 2 outcome variables. One was the presence or absence of organisms in bile culture, and the second one was the development of PEC.</p><p><strong>Results: </strong>The total number of patients was 280. Bile culture was positive in 195 (69.6%) patients, and post-ERCP cholangitis developed in 187 (66.8%) patients. The most common organism in BC was <i>Escherichia coli</i> (<i>E. coli</i>), in 82 (42%) patients. History of jaundice, abdominal pain, and weight loss on admission along with ERCP performed for common bile duct (CBD) stricture were independent predictors of positive BC and PEC, while advanced age was an additional risk factor for PEC.</p><p><strong>Conclusions: </strong>Microbial profile and risk factors for positive BC and PEC were evaluated. Advanced age, pre-operative jaundice, and prolonged biliary stasis are the independent risk factors for these conditions.</p>","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"19 3","pages":"296-302"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Przegla̜d Gastroenterologiczny
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1